ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19,324,689 | -12.2% | 180,234 | +0.0% | 0.27% | -17.4% |
| Q4 2022 | $22,011,124 | +72.8% | 180,227 | +46.1% | 0.33% | +69.9% |
| Q3 2022 | $12,736,000 | -0.4% | 123,340 | -10.3% | 0.19% | -6.8% |
| Q2 2022 | $12,783,000 | -15.8% | 137,510 | +6.3% | 0.21% | +11.3% |
| Q1 2022 | $15,178,000 | +38.9% | 129,325 | +59.2% | 0.19% | +66.1% |
| Q4 2021 | $10,930,000 | -15.5% | 81,246 | +0.1% | 0.11% | -26.8% |
| Q3 2021 | $12,934,000 | +74.9% | 81,147 | +44.3% | 0.15% | +56.1% |
| Q2 2021 | $7,397,000 | +9.6% | 56,233 | +7.3% | 0.10% | -2.0% |
| Q1 2021 | $6,752,000 | -78.0% | 52,389 | -71.6% | 0.10% | -79.9% |
| Q4 2020 | $30,741,000 | +20.7% | 184,320 | +11.6% | 0.50% | -5.0% |
| Q3 2020 | $25,478,000 | -7.5% | 165,101 | -11.4% | 0.52% | -21.9% |
| Q2 2020 | $27,555,000 | +48.1% | 186,307 | +12.7% | 0.67% | +7.7% |
| Q1 2020 | $18,608,000 | -13.9% | 165,244 | +6.3% | 0.62% | +8.2% |
| Q4 2019 | $21,621,000 | +57.4% | 155,412 | +9.0% | 0.58% | +28.6% |
| Q3 2019 | $13,736,000 | -16.8% | 142,605 | -0.5% | 0.45% | -13.5% |
| Q2 2019 | $16,505,000 | -17.9% | 143,331 | -16.1% | 0.52% | -31.5% |
| Q1 2019 | $20,111,000 | +1163.3% | 170,865 | +572.3% | 0.76% | +1010.3% |
| Q4 2018 | $1,592,000 | -55.0% | 25,414 | -49.1% | 0.07% | -37.6% |
| Q3 2018 | $3,536,000 | +34.2% | 49,906 | +26.0% | 0.11% | +22.5% |
| Q2 2018 | $2,634,000 | -17.8% | 39,593 | -19.2% | 0.09% | -21.2% |
| Q1 2018 | $3,206,000 | -11.0% | 49,021 | -50.6% | 0.11% | -19.3% |
| Q3 2017 | $3,601,000 | – | 99,328 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |